Europe direct-to-consumer laboratory testing market is projected to reach $1.59 billion by 2030

Genetic data privacy concerns, misinterpretation of test results, and lack of professional medical counselling could be challenges for the Europe direct-to-consumer laboratory testing market. However, the sample integrity and interference issues, regulatory concerns, lack of reimbursement, and limited test portfolio compared to conventional laboratory testing restrain the market's growth.